Anastase Dzudie1,2,3, Messaline Fodom Fomo2, Denis Georges Teuwafeu4, Clovis Nkoke2,4, Azabji Kenfack1, Divine Tim Bonghaseh2,5,6, Domin Ekaney2,7, Amy Tantchou8, Cabral Tantchou9, Laurent Serges Etoundi Ngoa1, Andre Pascal Kengne2,10, Simeon Pierre Choukem3,5,11. 1. Department of Physiology, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon. 2. Clinical Research Education Networking and Consultancy (CRENC), Douala, Cameroon. 3. Department of Internal Medicine and Subspecialties, Douala General Hospital, Douala, Cameroon. 4. Department of Internal Medicine, Buea Regional Hospital, Buea, Cameroon. 5. Health and Human Development (2HD) Research Network, Douala, Cameroon. 6. Baptist Hospital Mutengene, Mutengene, Cameroon. 7. Sub-divisional Hospital Batoke, Limbe, Cameroon. 8. Mariner Finance, Maryland, USA. 9. Shisong Cardiac Center, Kumbo, North West Region, Cameroon. 10. Non-communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa. 11. Faculty of Medicine and Pharmaceutical Sciences, University of Dschang, Dschang, Cameroon.
Abstract
INTRODUCTION: several international guidelines are available on drug treatment for hypertension, but the control of hypertension remains very poor in sub-Saharan Africa (SSA). We investigated the commonly prescribed antihypertensive drugs and their association with blood pressure (BP) control in adult Cameroonians. METHODS: we consecutively recruited hypertensive outpatients attending the Buea and Limbe Regional Hospitals (southwest region of Cameroon). Controlled BP was defined as BP < 140/90mmHg in hypertensive patients aged 60 years or younger, diabetics or patients with chronic kidney disease or a BP < 150/90mmHg in non-diabetic hypertensive patients older than 60 years of age (JNC8). RESULTS: of the 408 participants included (mean age 61.1 years), 67% were female. The median duration of hypertension was 6 years and the median duration of the current treatment was 22 weeks. Commonly prescribed antihypertensives were calcium channel blockers (CCB, 35.1%), thiazide/thiazide-like diuretics (TD/TLD, 26.1%) and angiotensin-converting enzyme inhibitors (ACEI, 19.5%). The median monthly cost of antihypertensive was 10279.6 CFA (approximately equal to US$ 172). Seventy percent (70%) of participants were receiving at least 2 drugs, with ACEI+TD/TLD, CCB+TD/TLD, and ACEI+CCB+TD/TLD being the most frequent combination. The rate of BP control was 52% overall, and 60% in participants on monotherapy. CONCLUSION: CCBs were the most prescribed single antihypertensive drugs in this setting while ACEI+TD/TLD was the most common combination. About half of patients were at target BP control levels Improving availability and affordability of these medications may improve hypertension management and control. Copyright: Anastase Dzudie et al.
INTRODUCTION: several international guidelines are available on drug treatment for hypertension, but the control of hypertension remains very poor in sub-Saharan Africa (SSA). We investigated the commonly prescribed antihypertensive drugs and their association with blood pressure (BP) control in adult Cameroonians. METHODS: we consecutively recruited hypertensive outpatients attending the Buea and Limbe Regional Hospitals (southwest region of Cameroon). Controlled BP was defined as BP < 140/90mmHg in hypertensive patients aged 60 years or younger, diabetics or patients with chronic kidney disease or a BP < 150/90mmHg in non-diabetic hypertensive patients older than 60 years of age (JNC8). RESULTS: of the 408 participants included (mean age 61.1 years), 67% were female. The median duration of hypertension was 6 years and the median duration of the current treatment was 22 weeks. Commonly prescribed antihypertensives were calcium channel blockers (CCB, 35.1%), thiazide/thiazide-like diuretics (TD/TLD, 26.1%) and angiotensin-converting enzyme inhibitors (ACEI, 19.5%). The median monthly cost of antihypertensive was 10279.6 CFA (approximately equal to US$ 172). Seventy percent (70%) of participants were receiving at least 2 drugs, with ACEI+TD/TLD, CCB+TD/TLD, and ACEI+CCB+TD/TLD being the most frequent combination. The rate of BP control was 52% overall, and 60% in participants on monotherapy. CONCLUSION: CCBs were the most prescribed single antihypertensive drugs in this setting while ACEI+TD/TLD was the most common combination. About half of patients were at target BP control levels Improving availability and affordability of these medications may improve hypertension management and control. Copyright: Anastase Dzudie et al.
Authors: Adela Alba-Leonel; Alfonso Carvajal; Immaculada Fierro; Fernando Castillo-Nájera; Oscar Campos-Ramos; Antonio Villa-Romero; Juan Molina-Guarneros Journal: Fundam Clin Pharmacol Date: 2016-05-05 Impact factor: 2.748
Authors: Samuel Kingue; Constant Ndong Ngoe; Alain Patrick Menanga; Ahmadou M Jingi; Jean Jacques N Noubiap; Betrand Fesuh; Christophe Nouedoui; Gervais Andze; Walinjom F T Muna Journal: J Clin Hypertens (Greenwich) Date: 2015-07-03 Impact factor: 3.738
Authors: Anastase Dzudie; André Pascal Kengne; Walinjom F T Muna; Hamadou Ba; Alain Menanga; Charles Kouam Kouam; Joseph Abah; Yves Monkam; Christian Biholong; Pierre Mintom; Félicité Kamdem; Armel Djomou; Jules Ndjebet; Cyrille Wambo; Henry Luma; Kathleen Blackett Ngu; Samuel Kingue Journal: BMJ Open Date: 2012-08-24 Impact factor: 2.692
Authors: David Guwatudde; Joan Nankya-Mutyoba; Robert Kalyesubula; Carien Laurence; Clement Adebamowo; IkeOluwapo Ajayi; Francis Bajunirwe; Marina Njelekela; Faraja S Chiwanga; Todd Reid; Jimmy Volmink; Hans-Olov Adami; Michelle D Holmes; Shona Dalal Journal: BMC Public Health Date: 2015-12-05 Impact factor: 3.295
Authors: E Gnugesser; C Chwila; S Brenner; A Deckert; P Dambach; J I Steinert; T Bärnighausen; O Horstick; K Antia; V R Louis Journal: BMC Public Health Date: 2022-08-08 Impact factor: 4.135